SCHEMBL23770799

SCHEMBL23770799

Fc1cccc(SNc2ccc(C(F)(F)F)c(Cl)n2)n1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 11/20 0.43
ADRB2 P07550 1/20 0.32
TRPV1 Q8NER1 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22338125 0.74 ADORA3 (0.34)
SCHEMBL22338280 0.74 TRPA1 (0.36)
SCHEMBL22163370 0.74
SCHEMBL22338246 0.71 RPS6KA3 (0.34) TRPV1
SCHEMBL29464949 0.71 XPO1 (0.44) XPO1
SCHEMBL19968808 0.71 XPO1 (0.44) XPO1
SCHEMBL8989468 0.70 XPO1 (0.58) XPO1ADRB2TRPV1
SCHEMBL22163547 0.70 NPC1 (0.32)
SCHEMBL22338037 0.70
SCHEMBL11010121 0.70 XPO1 (0.45) XPO1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3504194-B1 N-(PYRIDIN-2-YL)PYRIDINE-SULFONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-08-18 EP disclosed